University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 9 of 23
LITT and Pembrolizumab in Recurrent Brain Metastasis
NCT04187872
Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention
NCT04192071
Study of Pain Catastrophizing
NCT03836586
Platelet-Rich Fibrin in the Healing of Regional and Free Flaps
NCT04023474
Probiotic Detection and Persistence Study
NCT04065503
Sex Differences in Vascular Responses to Exercise
NCT04128215
Acute Effects of Alcohol Use on Chronic Orofacial Pain
NCT04019093
Mechanisms of Massage
NCT04108403
Engaging Patients in Weight Loss Tools
NCT04121312
Support and Tracking to Achieve Results (Project STAR)
NCT04116853
Lactobacillus Johnsonii in Children and Adolescents With T1D
NCT03961854
Muscle Delay Characterization
NCT04094571
High-Protein Food Snack for Dialysis Patients
NCT04134377
Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
NCT03947749
Inflammation and Protein Restriction
NCT03995979
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
NCT04006288
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
NCT03957239
Effect of Ketone Esters in Parkinson's Disease
NCT04477161
Attention Training on Smartphones
NCT04097340
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
NCT03774394
Implementing a Healthcare Provider Education Intervention in Rural Communities to Reduce Asthma Morbidity
NCT04060823
Understanding Cognition, Oxytocin & Pain in Elders
NCT03878589
Impact of Nuedexta on Bulbar Physiology and Function in ALS
NCT03883581
Swallowing Pressure Profiles in Healthy Adults
NCT03986554
Genotype-guided Supportive Care in Symptom Treatment of Cancer Patients
NCT03924557
Advance Care Planning in Cognitive Disorders Clinic
NCT03864965
Revitalize Cognition: Near Infrared Stimulation in Parkinson Patients
NCT06688357
The Burden of Access in Duchenne Muscular Dystrophy in the US
NCT03951675
Enhancing Cognition in Older Adults With Intermittent Hypoxia and Cognitive Training
NCT03957213
CODY (Co-design for You): An Immersive Technology Tool for Experiencing and Assessing Home Alterations
NCT03961282
FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma
NCT03906448
Total Knee Arthroplasty Biomechanics
NCT03671954
Impulsivity and Alcohol Response
NCT03736343
Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary?
NCT03797924
"Mind in Motion": Multimodal Imaging of Brain Activity to Investigate Walking and Mobility Decline in Older Adults
NCT03737760
Dietary Intervention and Gastrointestinal Function in Patients With Parkinson's Disease
NCT03851861
The Distal (SnUffbox) Radial artERy Access for Coronary Angiography and Interventions (SUPER-Prospective)
NCT03794687
Stimulation to Enhance Walking Post-SCI
NCT03702842
Emotion Study/Substudy: Flexible Brain Study
NCT03872414
Early Administration of Steroids in the Ambulance Setting
NCT03962894
Alcohol Monitor Validation
NCT03617705
Fermented Soy and Heartburn Symptom Relief
NCT03867591
Dosing of Methadone for Spine Surgery
NCT03605901
Feasibility of a Decision Aid for E-Cigarettes in Primary Care
NCT03836573
Development of a Risk Prediction Screening Tool for Opioid-Prescription Injury (STOP Injury) in Older Adults Initiated on Opioids From the Emergency Department
NCT03836235
RAAS Optimization for Acute CHF Patients
NCT03695120
Developing Self-Management Interventions After HCT
NCT03710031
Dysphagia and VFMI in Cardiac Patients
NCT03768739
Neurophysiologic Signatures of Trigeminal Neuralgia Pain
NCT03778177
Time Course Adaptations Using Deuterated Creatine (D3Cr) Method
NCT03573583
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.